吉非贝齐——一种新型降脂药。

J Med. 1980;11(2-3):107-16.

Thirty patients with type II and IV hyperlidemia were studied by a double blind cross over technic. Gemfibrozil at dosages of 1200 mg and 1600 mg a day was compared to 2000 mg daily of clofibrate. The effect of each drug regimen is described for the entire study population and for those who were found to be responders.

采用双盲交叉技术对30例II型和IV型高脂血症患者进行了研究。将每天1200毫克和1600毫克剂量的吉非贝齐与每天2000毫克的氯贝丁酯进行了比较。描述了每种药物治疗方案对整个研究人群以及那些被发现有反应者的效果。